Still, more Americans need to get vaccinated, experts urge
Opioid prescriptions for opioid-naive decreased then rebounded, while buprenorphine initiation remained lower
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 26 to 30, 2021. This …
Companies that meet certain stipulations will be allowed to return to U.S. waters by midsummer
April was the country’s deadliest month of the pandemic, with thousands of deaths daily
Excessive information seeking doubles the odds of elevated posttraumatic stress and anxiety/depression
A research team at the University of Pennsylvania (UPenn) has been working on preventing and treating genital herpes (HSV-2) for years and recently found success with an mRNA vaccine approach, even before the COVID-19 pandemic.
The goals of a HSV-2 vaccine are to keep the herpes virus dormant. Or if the virus escapes, prevent it from causing symptoms.
Professor Harvey M. Friedman demonstrated success in animal models in July 2020. This study found not only targeting entry molecules, but also targeting the HS-2 ability to evade the immune system.
If clinical trials are successful and the FDA approves the drug, it could be available across the United States later in 2021
Vaccine effectiveness against COVID-19 hospitalization estimated at 94 percent for full vaccination with Pfizer-BioNTech, Moderna vaccines
Schools that are not requiring vaccinations are instead offering incentives to encourage students to get their shots